Literature DB >> 23913962

Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.

Robbie B Mailliard1, Kellie N Smith, Ronald J Fecek, Giovanna Rappocciolo, Eduardo J M Nascimento, Ernesto T Marques, Simon C Watkins, James I Mullins, Charles R Rinaldo.   

Abstract

The ability of HIV-1 to rapidly accumulate mutations provides the virus with an effective means of escaping CD8(+) CTL responses. In this study, we describe how subtle alterations in CTL epitopes expressed by naturally occurring HIV-1 variants can result in an incomplete escape from CTL recognition, providing the virus with a selective advantage. Rather than paralyzing the CTL response, these epitope modifications selectively induce the CTL to produce proinflammatory cytokines in the absence of target killing. Importantly, instead of dampening the immune response through CTL elimination of variant Ag-expressing immature dendritic cells (DC), a positive CTL-to-DC immune feedback loop dominates whereby the immature DC differentiate into mature proinflammatory DC. Moreover, these CTL-programmed DC exhibit a superior capacity to mediate HIV-1 trans-infection of T cells. This discordant induction of CTL helper activity in the absence of killing most likely contributes to the chronic immune activation associated with HIV-1 infection, and can be used by HIV-1 to promote viral dissemination and persistence. Our findings highlight the need to address the detrimental potential of eliciting dysfunctional cross-reactive memory CTL responses when designing and implementing anti-HIV-1 immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913962      PMCID: PMC3786204          DOI: 10.4049/jimmunol.1300373

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

Authors:  L Musey; J Hughes; T Schacker; T Shea; L Corey; M J McElrath
Journal:  N Engl J Med       Date:  1997-10-30       Impact factor: 91.245

2.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.

Authors:  P Klenerman; R M Zinkernagel
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

4.  Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.

Authors:  C Brander; P J Goulder; K Luzuriaga; O O Yang; K E Hartman; N G Jones; B D Walker; S A Kalams
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

5.  Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.

Authors:  C M Hay; D J Ruhl; N O Basgoz; C C Wilson; J M Billingsley; M P DePasquale; R T D'Aquila; S M Wolinsky; J M Crawford; D C Montefiori; B D Walker
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

Authors:  Robert Maile; Catherine A Siler; Samantha E Kerry; Katherine E Midkiff; Edward J Collins; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

Authors:  C Brander; K E Hartman; A K Trocha; N G Jones; R P Johnson; B Korber; P Wentworth; S P Buchbinder; S Wolinsky; B D Walker; S A Kalams
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.

Authors:  S Pascolo; N Bervas; J M Ure; A G Smith; F A Lemonnier; B Pérarnau
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

10.  CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivo.

Authors:  C Ruedl; M Kopf; M F Bachmann
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  26 in total

Review 1.  Dendritic Cell-Based Cancer Vaccines.

Authors:  Patricia M Santos; Lisa H Butterfield
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer.

Authors:  Colleen R Zaccard; Simon C Watkins; Velpandi Ayyavoo; Charles R Rinaldo; Robbie B Mailliard
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

3.  Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration.

Authors:  Elizabeth J Phillips; Simon A Mallal
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

Review 4.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

5.  Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1.

Authors:  Kellie N Smith; Robbie B Mailliard; Brendan B Larsen; Kim Wong; Phalguni Gupta; James I Mullins; Charles R Rinaldo
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

6.  Programming T cell Killers for an HIV Cure: Teach the New Dogs New Tricks and Let the Sleeping Dogs Lie.

Authors:  Kellie N Smith; Robbie B Mailliard; Charles R Rinaldo
Journal:  For Immunopathol Dis Therap       Date:  2015

Review 7.  Linked in: immunologic membrane nanotube networks.

Authors:  C R Zaccard; C R Rinaldo; R B Mailliard
Journal:  J Leukoc Biol       Date:  2016-03-01       Impact factor: 4.962

8.  HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.

Authors:  Cristina Andrés; Montserrat Plana; Alberto C Guardo; Carmen Alvarez-Fernández; Nuria Climent; Teresa Gallart; Agathe León; Bonaventura Clotet; Brigitte Autran; Nicolas Chomont; Josep M Gatell; Sonsoles Sánchez-Palomino; Felipe García
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

9.  Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.

Authors:  Tatiana M Garcia-Bates; Mariana L Palma; Chengli Shen; Andrea Gambotto; Bernard J C Macatangay; Robert L Ferris; Charles R Rinaldo; Robbie B Mailliard
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

10.  Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.

Authors:  Justine E Sunshine; Brendan B Larsen; Brandon Maust; Ellie Casey; Wenje Deng; Lennie Chen; Dylan H Westfall; Moon Kim; Hong Zhao; Suvankar Ghorai; Erinn Lanxon-Cookson; Morgane Rolland; Ann C Collier; Janine Maenza; James I Mullins; Nicole Frahm
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.